GlassScriptPhysician profile
Charles S Carroll
NPI 1003846353
$11,832.75
in general payments reported to CMS, 2019-2025
34 companies · $490 in 2025
The $490 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $310 · 2021: $743 · 2022: $4,753 · 2023: $4,547 · 2024: $286 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $1,323.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,401.73 | 2022-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Abbvie INC. | $1,041.36 | 2019-2023 | Liletta, Lo Loestrin Fe, Vraylar |
| Fujirebio Diagnostics, Incorporated | $350.00 | 2022 | |
| Amgen INC. | $286.38 | 2019-2022 | |
| Astellas Pharma US INC | $201.75 | 2020-2025 | Veozah |
| Caldera Medical, INC | $186.14 | 2019 | |
| Mayne Pharma Commercial LLC | $184.89 | 2023-2025 | |
| Medical Device Business Services, INC. | $149.03 | 2025 | Harmonic |
| Hologic Sales and Service, LLC | $147.21 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Gynesonics, INC. | $143.53 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.33 | 2020-2021 | |
| Allergan, INC. | $64.92 | 2020 | |
| Daiichi Sankyo INC. | $45.50 | 2021 | |
| Scynexis, INC. | $44.03 | 2021-2022 | |
| Pfizer INC. | $41.39 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $37.11 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $33.96 | 2019-2020 | |
| Convatec INC. | $29.01 | 2025 | |
| Sage Therapeutics, LLC | $28.75 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $28.38 | 2024 | |
| Evofem Biosciences, INC. | $28.25 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.11 | 2019-2023 | |
| Novo Nordisk INC | $27.83 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.46 | 2022 | |
| Merck Sharp & Dohme LLC | $17.28 | 2020 | |
| Sumitomo Pharma America, INC. | $16.73 | 2025 | Gemtesa |
| Lilly USA, LLC | $15.51 | 2025 | Zepbound |
| Applied Medical Resources Corporation | $15.39 | 2019 | |
| Exeltis, USA INC. | $14.99 | 2022 | |
| Smith+Nephew, INC. | $14.38 | 2024 | Pico 7 |
| Axonics, INC. | $14.27 | 2021 | |
| Radius Health, INC. | $12.50 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.01 | 2019 | |
| Channel Medsystems, INC. | $9.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.